DE3574710D1 - Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. - Google Patents

Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.

Info

Publication number
DE3574710D1
DE3574710D1 DE8585902248T DE3574710T DE3574710D1 DE 3574710 D1 DE3574710 D1 DE 3574710D1 DE 8585902248 T DE8585902248 T DE 8585902248T DE 3574710 T DE3574710 T DE 3574710T DE 3574710 D1 DE3574710 D1 DE 3574710D1
Authority
DE
Germany
Prior art keywords
cells
new
tumour
subunit
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585902248T
Other languages
English (en)
Inventor
H Ransom
P Mccabe
V Haspel
Nicholas Pomato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Litton Bionetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Litton Bionetics Inc filed Critical Litton Bionetics Inc
Application granted granted Critical
Publication of DE3574710D1 publication Critical patent/DE3574710D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8585902248T 1984-04-13 1985-04-11 Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. Expired - Fee Related DE3574710D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60030384A 1984-04-13 1984-04-13
PCT/US1985/000626 WO1985004662A1 (en) 1984-04-13 1985-04-11 Leukoregulin, an antitumor lymphokine, and its therapeutic uses

Publications (1)

Publication Number Publication Date
DE3574710D1 true DE3574710D1 (de) 1990-01-18

Family

ID=24403068

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585902248T Expired - Fee Related DE3574710D1 (de) 1984-04-13 1985-04-11 Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.

Country Status (9)

Country Link
EP (1) EP0179127B1 (de)
JP (2) JP2562014B2 (de)
AT (1) ATE48617T1 (de)
AU (2) AU592529B2 (de)
DE (1) DE3574710D1 (de)
DK (2) DK170781B1 (de)
FI (1) FI85867C (de)
NO (1) NO170423C (de)
WO (1) WO1985004662A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE48617T1 (de) * 1984-04-13 1989-12-15 Litton Bionetics Inc Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6087166A (en) 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
CA2652346A1 (en) 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
ES2931180T3 (es) 2011-05-19 2022-12-27 Fund Publica Andaluza Progreso Y Salud Sistema de tipo Tet-on lentivírico de promotor dual muy inducible

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4403035A (en) * 1981-06-19 1983-09-06 Regents Of The University Of Minnesota In vitro DNA-Protein viral assembly and gene cloning system
DE3138230A1 (de) * 1981-09-25 1983-04-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von makrophagen- aktivierungsfaktor (maf)
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
ATE48617T1 (de) * 1984-04-13 1989-12-15 Litton Bionetics Inc Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.

Also Published As

Publication number Publication date
EP0179127A1 (de) 1986-04-30
AU4234185A (en) 1985-11-01
DK98692A (da) 1992-08-04
JP2564245B2 (ja) 1996-12-18
DK98692D0 (da) 1992-08-04
DK170781B1 (da) 1996-01-15
NO854994L (no) 1985-12-12
AU5365390A (en) 1990-09-20
JPS61501853A (ja) 1986-08-28
FI85867B (fi) 1992-02-28
AU592529B2 (en) 1990-01-18
EP0179127B1 (de) 1989-12-13
DK562285D0 (da) 1985-12-04
AU641386B2 (en) 1993-09-23
JP2562014B2 (ja) 1996-12-11
NO170423C (no) 1992-10-14
EP0179127A4 (de) 1986-08-21
DK170423B1 (da) 1995-08-28
FI854803A (fi) 1985-12-04
JPH06253832A (ja) 1994-09-13
ATE48617T1 (de) 1989-12-15
FI85867C (fi) 1992-06-10
DK562285A (da) 1985-12-04
WO1985004662A1 (en) 1985-10-24
FI854803A0 (fi) 1985-12-04
NO170423B (no) 1992-07-06

Similar Documents

Publication Publication Date Title
DK0702563T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer og hyperproliferative sygdomme
CA2202028A1 (en) Tie-2 ligands, methods of making and uses thereof
WO1996011269B1 (en) Tie-2 ligands, methods of making and uses thereof
DE3268915D1 (en) Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions
Kudlow et al. Inability of anti-epidermal growth factor receptor monoclonal antibody to block “autocrine” growth stimulation in transforming growth factor-secreting melanoma cells.
DE3574710D1 (de) Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.
Tagliaferri et al. Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH3T3 cells transfected with Ha-MuSV DNA
CN108884138A (zh) 去免疫的治疗性组合物和方法
CN110527680A (zh) 一种透明质酸裂解酶及其基因与应用
AU669857B2 (en) Mutated growth factor receptor as medicament and its use for treating cancer
Karpas A humoral cytotoxic substance produced by a human killer cell line
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector
CN111793116B (zh) 一种透皮七肽、含有该透皮七肽的美容组合物及制备方法
Matsumoto et al. Stimulation of bone collagenase synthesis by mouse fibrosarcoma in resorbing bone in vitro culture
MX9707617A (es) Factor de crecimiento de criptina humano.
JPH03505575A (ja) 幹細胞阻害剤
Greenberger et al. Biochemical Purification of a CSF-1 like Molecule Released during Malignant Transformation of IL-3 Dependent Hematopoietic Progenitor cell lines Cocultivated with Gamma Irradiated Clonal Marrow Stromal cell lines
CN100425699C (zh) scFvC6.5-TNF-α融合基因和蛋白及制备
CN1348005A (zh) 重构、靶向半胱天冬酶基因的制备及其用途
CN112210014A (zh) 一种用于治疗动物肿瘤的融合蛋白及组合物
CN106349383A (zh) 人sfrp1变体及其应用
CN106349376A (zh) 人sfrp1变体及其应用
CN106349377A (zh) 人sfrp1变体及其应用
CN106349381A (zh) 人sfrp1变体及其应用
CN106349382A (zh) 人sfrp1变体及其应用

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8339 Ceased/non-payment of the annual fee